Chemed Corporation $CHE Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its stake in shares of Chemed Corporation (NYSE:CHE) by 6.5% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 80,080 shares of the company’s stock after acquiring an additional 4,865 shares during the period. Envestnet Asset Management Inc. owned approximately 0.55% of Chemed worth $35,855,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Creekmur Asset Management LLC purchased a new stake in shares of Chemed during the second quarter valued at approximately $28,000. First Horizon Corp purchased a new stake in Chemed during the 3rd quarter worth $31,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Chemed during the 3rd quarter worth $45,000. Parkside Financial Bank & Trust boosted its position in Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after buying an additional 44 shares during the last quarter. Finally, HM Payson & Co. grew its stake in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after acquiring an additional 27 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

CHE has been the topic of several recent analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Finally, Royal Bank Of Canada dropped their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Chemed has an average rating of “Moderate Buy” and an average price target of $555.50.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.29% of the stock is currently owned by company insiders.

Chemed Price Performance

Shares of CHE opened at $461.97 on Thursday. The stock has a market capitalization of $6.54 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The business’s fifty day moving average price is $438.06 and its 200 day moving average price is $441.70. Chemed Corporation has a 12-month low of $408.42 and a 12-month high of $623.60.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.